{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:15:18Z","timestamp":1774415718483,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1016\/s0014-2999(97)81951-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T11:03:23Z","timestamp":1027595003000},"page":"R3-R5","source":"Crossref","is-referenced-by-count":153,"title":["Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation"],"prefix":"10.1016","volume":"338","author":[{"given":"Hans","family":"Rollema","sequence":"first","affiliation":[]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Anne W","family":"Schmidt","sequence":"additional","affiliation":[]},{"given":"Stevin H","family":"Zorn","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0014-2999(97)81951-6_BIB1","first-page":"1452","article-title":"Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine","volume":"268","author":"Meltzer","year":"1994","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/S0014-2999(97)81951-6_BIB2","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1471-4159.1990.tb01230.x","article-title":"Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from the prefrontal cortex, nucleus accumbens and striatum of the rat: An in vivo microdialysis study","volume":"54","author":"Moghaddam","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/S0014-2999(97)81951-6_BIB3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0028-3908(95)00170-0","article-title":"Clozapine is a partial agonist at human serotonin 5-HT1A receptors","volume":"25","author":"Newman-Tancredi","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0014-2999(97)81951-6_BIB4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0014-2999(93)90979-R","article-title":"Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists","volume":"239","author":"Santiago","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(97)81951-6_BIB5","first-page":"101","article-title":"Ziprasidone (CP-88,059): A new antipsychotic with combined dopamine and serotonin receptor antagonist activity","volume":"275","author":"Seeger","year":"1995","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/S0014-2999(97)81951-6_BIB6","first-page":"159","article-title":"Ziprasidone: A novel antipsychotic with unique pharmacology and therapeutic potential","volume":"4","author":"Tandon","year":"1997","journal-title":"J. Serotonin Res."},{"key":"10.1016\/S0014-2999(97)81951-6_BIB7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(96)00150-1","article-title":"Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex","volume":"305","author":"Wedzony","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(97)81951-6_BIB8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00013-C","article-title":"Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for a common ground","volume":"16","author":"Weinberger","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0014-2999(97)81951-6_BIB9","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0922-4106(94)90047-7","article-title":"Clozapine is a potent and selective muscarinic M4 receptor agonist","volume":"269","author":"Zorn","year":"1994","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299997819516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299997819516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T12:50:26Z","timestamp":1556369426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299997819516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["S0014299997819516"],"URL":"https:\/\/doi.org\/10.1016\/s0014-2999(97)81951-6","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}